PROFESSIONAL EDITION

The largest community of pharma leaders

Semma Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced that it has expanded its leadership team with the addition of Mary Kay Fenton as Chief Financial Officer. “I am absolutely thrilled to welcome Mary Kay to our team. She will not only help us to streamline and optimize our operations, but further expand our ability to execute on our strategic vision to deliver a functional cure …

 

 

 

http://www.businesswire.com/news/home/20190529005051/en/Semma-Therapeutics-Appoints-Mary-Kay-Fenton-Chief/

Recent Articles